These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8866037

  • 21. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Sweeney AT, Tangpricha V, Weinberg J, Malabanan AO, Chimeh FN, Holick MF.
    Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
    [Abstract] [Full Text] [Related]

  • 22. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 23. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N.
    Menopause; 2003 Jan; 10(4):286-91. PubMed ID: 12851511
    [Abstract] [Full Text] [Related]

  • 24. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Jan; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 25. Comparison of pharmacokinetic profiles of a 17 beta-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state.
    Paoletti AM, Pilia I, Nannipieri F, Bigini C, Melis GB.
    Maturitas; 2001 Dec 14; 40(3):203-9. PubMed ID: 11731181
    [Abstract] [Full Text] [Related]

  • 26. An evaluation of bioequivalence of two 7-day 17beta-estradiol transdermal delivery systems by anatomical site.
    Harrison LL, Harari D.
    J Clin Pharmacol; 2002 Oct 14; 42(10):1134-41. PubMed ID: 12362928
    [Abstract] [Full Text] [Related]

  • 27. Absorption, bioavailability, and partner transfer of estradiol from a topical emulsion.
    Taylor MB, Gutierrez MJ.
    Pharmacotherapy; 2008 Jun 14; 28(6):712-8. PubMed ID: 18503399
    [Abstract] [Full Text] [Related]

  • 28. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr 14; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 29. The effects of skin-to-skin contact, application site washing, and sunscreen use on the pharmacokinetics of estradiol from a metered-dose transdermal spray.
    Schumacher RJ, Gattermeir DJ, Peterson CA, Wisdom C, Day WW.
    Menopause; 2009 Apr 14; 16(1):177-83. PubMed ID: 18779758
    [Abstract] [Full Text] [Related]

  • 30. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 Apr 14; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 31. Comparative bioequivalence studies with Estradot and Menorest transdermal systems.
    Hossain M, Quebe-Fehling E, Sergejew T, Schmidt G, Skerjanec A, Cohen A, Krinsky L, Ibarra de Palacios P.
    Maturitas; 2003 Nov 20; 46(3):187-98. PubMed ID: 14585521
    [Abstract] [Full Text] [Related]

  • 32. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.
    Obstet Gynecol; 2007 Mar 20; 109(3):588-96. PubMed ID: 17329509
    [Abstract] [Full Text] [Related]

  • 33. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
    Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW.
    Obstet Gynecol; 1997 Mar 20; 89(3):340-5. PubMed ID: 9052581
    [Abstract] [Full Text] [Related]

  • 34. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG, Dai Y.
    Clin Ther; 2004 Dec 20; 26(12):2056-65. PubMed ID: 15823769
    [Abstract] [Full Text] [Related]

  • 35. Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women.
    Brennan JJ, Lu Z, Whitman M, Stafiniak P, van der Hoop RG.
    Ther Drug Monit; 2001 Apr 20; 23(2):134-8. PubMed ID: 11294513
    [Abstract] [Full Text] [Related]

  • 36. The pharmacokinetics of intravenous estradiol--a preliminary study.
    White CM, Ferraro-Borgida MJ, Fossati AT, McGill CC, Ahlberg AW, Feng YJ, Heller GV, Chow MS.
    Pharmacotherapy; 1998 Apr 20; 18(6):1343-6. PubMed ID: 9855336
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the pharmacokinetics of 17 beta-estradiol after a single 4-day application of Oesclim 50, Oesclim 100, and Vivelle 0.05 (Menorest 50) transdermal delivery systems.
    Guichard JP, Sauron R, Jones AB.
    J Clin Pharmacol; 1999 Aug 20; 39(8):811-6. PubMed ID: 10434233
    [Abstract] [Full Text] [Related]

  • 38. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women.
    Rohr UD, Nauert C, Stehle B.
    Maturitas; 1999 Sep 24; 33(1):45-58. PubMed ID: 10585173
    [Abstract] [Full Text] [Related]

  • 39. Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol.
    Morgan TM, O'Sullivan HM, Reed BL, Finnin BC.
    J Pharm Sci; 1998 Oct 24; 87(10):1226-8. PubMed ID: 9758681
    [Abstract] [Full Text] [Related]

  • 40. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Maturitas; 2005 Jan 10; 50(1):19-29. PubMed ID: 15590210
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.